The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Melatonin Receptor Agonists Market Research Report 2024
Synopsis
Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
Global Melatonin Receptor Agonists market is projected to reach US$ 451.7 million in 2029, increasing from US$ 232 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Melatonin Receptor Agonists market research.
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Melatonin Receptor Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Segment by Type
Ramelteon
Tasimelteon
Agomelatine
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Melatonin Receptor Agonists report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
Global Melatonin Receptor Agonists market is projected to reach US$ 451.7 million in 2029, increasing from US$ 232 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Melatonin Receptor Agonists market research.
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Melatonin Receptor Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Segment by Type
Ramelteon
Tasimelteon
Agomelatine
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Melatonin Receptor Agonists report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Melatonin Receptor Agonists Market Overview
1.1 Product Overview and Scope of Melatonin Receptor Agonists
1.2 Melatonin Receptor Agonists Segment by Type
1.2.1 Global Melatonin Receptor Agonists Market Value Comparison by Type (2023-2029)
1.2.2 Ramelteon
1.2.3 Tasimelteon
1.2.4 Agomelatine
1.2.5 Other
1.3 Melatonin Receptor Agonists Segment by Application
1.3.1 Global Melatonin Receptor Agonists Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Melatonin Receptor Agonists Market Size Estimates and Forecasts
1.4.1 Global Melatonin Receptor Agonists Revenue 2018-2029
1.4.2 Global Melatonin Receptor Agonists Sales 2018-2029
1.4.3 Global Melatonin Receptor Agonists Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Melatonin Receptor Agonists Market Competition by Manufacturers
2.1 Global Melatonin Receptor Agonists Sales Market Share by Manufacturers (2018-2023)
2.2 Global Melatonin Receptor Agonists Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Melatonin Receptor Agonists Average Price by Manufacturers (2018-2023)
2.4 Global Melatonin Receptor Agonists Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Melatonin Receptor Agonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melatonin Receptor Agonists, Product Type & Application
2.7 Melatonin Receptor Agonists Market Competitive Situation and Trends
2.7.1 Melatonin Receptor Agonists Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Melatonin Receptor Agonists Players Market Share by Revenue
2.7.3 Global Melatonin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Melatonin Receptor Agonists Retrospective Market Scenario by Region
3.1 Global Melatonin Receptor Agonists Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Melatonin Receptor Agonists Global Melatonin Receptor Agonists Sales by Region: 2018-2029
3.2.1 Global Melatonin Receptor Agonists Sales by Region: 2018-2023
3.2.2 Global Melatonin Receptor Agonists Sales by Region: 2024-2029
3.3 Global Melatonin Receptor Agonists Global Melatonin Receptor Agonists Revenue by Region: 2018-2029
3.3.1 Global Melatonin Receptor Agonists Revenue by Region: 2018-2023
3.3.2 Global Melatonin Receptor Agonists Revenue by Region: 2024-2029
3.4 North America Melatonin Receptor Agonists Market Facts & Figures by Country
3.4.1 North America Melatonin Receptor Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Melatonin Receptor Agonists Sales by Country (2018-2029)
3.4.3 North America Melatonin Receptor Agonists Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Melatonin Receptor Agonists Market Facts & Figures by Country
3.5.1 Europe Melatonin Receptor Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Melatonin Receptor Agonists Sales by Country (2018-2029)
3.5.3 Europe Melatonin Receptor Agonists Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melatonin Receptor Agonists Market Facts & Figures by Country
3.6.1 Asia Pacific Melatonin Receptor Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Melatonin Receptor Agonists Sales by Country (2018-2029)
3.6.3 Asia Pacific Melatonin Receptor Agonists Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Melatonin Receptor Agonists Market Facts & Figures by Country
3.7.1 Latin America Melatonin Receptor Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Melatonin Receptor Agonists Sales by Country (2018-2029)
3.7.3 Latin America Melatonin Receptor Agonists Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Melatonin Receptor Agonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Melatonin Receptor Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Melatonin Receptor Agonists Sales by Country (2018-2029)
3.8.3 Middle East and Africa Melatonin Receptor Agonists Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melatonin Receptor Agonists Sales by Type (2018-2029)
4.1.1 Global Melatonin Receptor Agonists Sales by Type (2018-2023)
4.1.2 Global Melatonin Receptor Agonists Sales by Type (2024-2029)
4.1.3 Global Melatonin Receptor Agonists Sales Market Share by Type (2018-2029)
4.2 Global Melatonin Receptor Agonists Revenue by Type (2018-2029)
4.2.1 Global Melatonin Receptor Agonists Revenue by Type (2018-2023)
4.2.2 Global Melatonin Receptor Agonists Revenue by Type (2024-2029)
4.2.3 Global Melatonin Receptor Agonists Revenue Market Share by Type (2018-2029)
4.3 Global Melatonin Receptor Agonists Price by Type (2018-2029)
5 Segment by Application
5.1 Global Melatonin Receptor Agonists Sales by Application (2018-2029)
5.1.1 Global Melatonin Receptor Agonists Sales by Application (2018-2023)
5.1.2 Global Melatonin Receptor Agonists Sales by Application (2024-2029)
5.1.3 Global Melatonin Receptor Agonists Sales Market Share by Application (2018-2029)
5.2 Global Melatonin Receptor Agonists Revenue by Application (2018-2029)
5.2.1 Global Melatonin Receptor Agonists Revenue by Application (2018-2023)
5.2.2 Global Melatonin Receptor Agonists Revenue by Application (2024-2029)
5.2.3 Global Melatonin Receptor Agonists Revenue Market Share by Application (2018-2029)
5.3 Global Melatonin Receptor Agonists Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Corporation Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Pharmaceutical Melatonin Receptor Agonists Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Vanda Pharmaceuticals
6.2.1 Vanda Pharmaceuticals Corporation Information
6.2.2 Vanda Pharmaceuticals Description and Business Overview
6.2.3 Vanda Pharmaceuticals Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Vanda Pharmaceuticals Melatonin Receptor Agonists Product Portfolio
6.2.5 Vanda Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Melatonin Receptor Agonists Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Natrol
6.4.1 Natrol Corporation Information
6.4.2 Natrol Description and Business Overview
6.4.3 Natrol Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Natrol Melatonin Receptor Agonists Product Portfolio
6.4.5 Natrol Recent Developments/Updates
6.5 Pharmavite
6.5.1 Pharmavite Corporation Information
6.5.2 Pharmavite Description and Business Overview
6.5.3 Pharmavite Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pharmavite Melatonin Receptor Agonists Product Portfolio
6.5.5 Pharmavite Recent Developments/Updates
6.6 Nature's Bounty
6.6.1 Nature's Bounty Corporation Information
6.6.2 Nature's Bounty Description and Business Overview
6.6.3 Nature's Bounty Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nature's Bounty Melatonin Receptor Agonists Product Portfolio
6.6.5 Nature's Bounty Recent Developments/Updates
6.7 Jameison
6.6.1 Jameison Corporation Information
6.6.2 Jameison Description and Business Overview
6.6.3 Jameison Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jameison Melatonin Receptor Agonists Product Portfolio
6.7.5 Jameison Recent Developments/Updates
6.8 Rexall Sundown
6.8.1 Rexall Sundown Corporation Information
6.8.2 Rexall Sundown Description and Business Overview
6.8.3 Rexall Sundown Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Rexall Sundown Melatonin Receptor Agonists Product Portfolio
6.8.5 Rexall Sundown Recent Developments/Updates
6.9 GNC
6.9.1 GNC Corporation Information
6.9.2 GNC Description and Business Overview
6.9.3 GNC Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GNC Melatonin Receptor Agonists Product Portfolio
6.9.5 GNC Recent Developments/Updates
6.10 Xiu Zheng
6.10.1 Xiu Zheng Corporation Information
6.10.2 Xiu Zheng Description and Business Overview
6.10.3 Xiu Zheng Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Xiu Zheng Melatonin Receptor Agonists Product Portfolio
6.10.5 Xiu Zheng Recent Developments/Updates
6.11 Church & Dwight
6.11.1 Church & Dwight Corporation Information
6.11.2 Church & Dwight Melatonin Receptor Agonists Description and Business Overview
6.11.3 Church & Dwight Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Church & Dwight Melatonin Receptor Agonists Product Portfolio
6.11.5 Church & Dwight Recent Developments/Updates
6.12 BY-HEALTH
6.12.1 BY-HEALTH Corporation Information
6.12.2 BY-HEALTH Melatonin Receptor Agonists Description and Business Overview
6.12.3 BY-HEALTH Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BY-HEALTH Melatonin Receptor Agonists Product Portfolio
6.12.5 BY-HEALTH Recent Developments/Updates
6.13 Solgar
6.13.1 Solgar Corporation Information
6.13.2 Solgar Melatonin Receptor Agonists Description and Business Overview
6.13.3 Solgar Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Solgar Melatonin Receptor Agonists Product Portfolio
6.13.5 Solgar Recent Developments/Updates
6.14 Biotics Research
6.14.1 Biotics Research Corporation Information
6.14.2 Biotics Research Melatonin Receptor Agonists Description and Business Overview
6.14.3 Biotics Research Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Biotics Research Melatonin Receptor Agonists Product Portfolio
6.14.5 Biotics Research Recent Developments/Updates
6.15 Now Food
6.15.1 Now Food Corporation Information
6.15.2 Now Food Melatonin Receptor Agonists Description and Business Overview
6.15.3 Now Food Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Now Food Melatonin Receptor Agonists Product Portfolio
6.15.5 Now Food Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melatonin Receptor Agonists Industry Chain Analysis
7.2 Melatonin Receptor Agonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melatonin Receptor Agonists Production Mode & Process
7.4 Melatonin Receptor Agonists Sales and Marketing
7.4.1 Melatonin Receptor Agonists Sales Channels
7.4.2 Melatonin Receptor Agonists Distributors
7.5 Melatonin Receptor Agonists Customers
8 Melatonin Receptor Agonists Market Dynamics
8.1 Melatonin Receptor Agonists Industry Trends
8.2 Melatonin Receptor Agonists Market Drivers
8.3 Melatonin Receptor Agonists Market Challenges
8.4 Melatonin Receptor Agonists Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
